Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy
ICD-10 E09.33 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy.
E09.33 refers to diabetes mellitus that has been induced by drugs or chemicals, characterized by the presence of moderate nonproliferative diabetic retinopathy. This condition arises when certain medications or toxic substances lead to insulin resistance or impaired insulin secretion, resulting in elevated blood glucose levels. Nonproliferative diabetic retinopathy is a common complication of diabetes, where damage occurs to the retinal blood vessels, leading to vision problems. Moderate nonproliferative diabetic retinopathy is defined by the presence of microaneurysms, retinal hemorrhages, and exudates, but without the growth of new blood vessels (neovascularization). Management of this condition often involves controlling blood glucose levels through lifestyle modifications, oral hypoglycemic agents, or insulin therapy, alongside regular ophthalmologic evaluations to monitor retinal health. The HbA1c levels in patients with drug-induced diabetes can vary, but maintaining levels below 7% is generally recommended to prevent complications. Understanding the underlying cause of diabetes, particularly in cases induced by medications, is crucial for effective treatment and management.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with new-onset diabetes after starting a specific medication.
Ensure clear documentation of the drug responsible for diabetes and its management.
Retinal examination findings, grading of retinopathy severity, and treatment plans.
Patients with diabetes presenting for routine eye exams or vision changes.
Document the relationship between diabetes management and retinal health.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any changes in medication.
Endocrinologists should ensure comprehensive documentation of diabetes control.
Several classes of medications can induce diabetes, including corticosteroids, certain antipsychotics, and some antihypertensive agents. It is essential to review the patient's medication history to identify potential causes.
